Human Phenotype Ontology 
Grandparent Node:
expand
Morphological central nervous system abnormality (HP:0002011)help
Parent Node:
expand
Abnormal glial cell morphology (HP:0100705)help
..Starting node
..expand
Gliosis (HP:0002171)help
Term ID: 2171
Name: Gliosis
Synonym: Cerebral gliosis; Excess astrocytes in brain
Definition: Gliosis is the focal proliferation of glial cells in the central nervous system.
Comments:
Reference: HP:0002171
Genes and Diseases:
 
       Child Nodes:
........expandMyelin-dependent gliosis (HP:0006990) help
........expandBasal ganglia gliosis (HP:0006999) help
........expandSubstantia nigra gliosis (HP:0011960) help
........expandCerebellar gliosis (HP:0012698) help
........expandHypothalamic gliosis (HP:0025037) help

 Sister Nodes: 
..expandAbnormal astrocyte morphology (HP:0100707) help
..expandAbnormal microglia morphology (HP:0100708) help
..expandAbnormal oligodendroglia morphology (HP:0100706) help
..expandAstrocytosis (HP:0002446) help
..expandGlioma (HP:0009733) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0002171HP:0002171Gliosis0ADAR CL E G H103225ORPHA:225154Familial infantile bilateral striatal necrosis116
HP:0002171HP:0002171Gliosis0ADH1C CL E G H126251OMIM:168600Parkinson disease, late-onset4
HP:0002171HP:0002171Gliosis0AKT3 CL E G H10000393ORPHA:99802HemimegalencephalyHP:0040283 - Occasional19
HP:0002171HP:0002171Gliosis0AP4M1 CL E G H9179574OMIM:612936Spastic paraplegia 50, autosomal recessive.41
HP:0002171HP:0002171Gliosis0ARX CL E G H17030218060OMIM:300215Lissencephaly, X-linked, 2.166
HP:0002171HP:0002171Gliosis0ATP6 CL E G H45087414ORPHA:225154Familial infantile bilateral striatal necrosis
HP:0002171HP:0002171Gliosis0ATP6V1A CL E G H523851OMIM:617403Cutis laxa, autosomal recessive, type IID.3
HP:0002171HP:0002171Gliosis0ATXN2 CL E G H631110555OMIM:168600Parkinson disease, late-onset11
HP:0002171HP:0002171Gliosis0ATXN3 CL E G H42877106OMIM:109150Machado-Joseph disease.14
HP:0002171HP:0002171Gliosis0ATXN3 CL E G H42877106ORPHA:276238Machado-Joseph disease type 114
HP:0002171HP:0002171Gliosis0ATXN3 CL E G H42877106ORPHA:276241Machado-Joseph disease type 214
HP:0002171HP:0002171Gliosis0ATXN3 CL E G H42877106ORPHA:276244Machado-Joseph disease type 314
HP:0002171HP:0002171Gliosis0ATXN8OS CL E G H631510561OMIM:168600Parkinson disease, late-onset1
HP:0002171HP:0002171Gliosis0AVP CL E G H551894OMIM:125700Diabetes insipidus, Neurohypophyseal type.22
HP:0002171HP:0002171Gliosis0BCS1L CL E G H6171020OMIM:124000Mitochondrial complex III deficiency, nuclear type 172
HP:0002171HP:0002171Gliosis0BRAT1 CL E G H22192721701OMIM:614498Rigidity and multifocal seizure syndrome, lethal neonatal.20
HP:0002171HP:0002171Gliosis0C9ORF72 CL E G H20322828337OMIM:105550Amyotrophic lateral sclerosis and/or frontotemporal dementia 1.56
HP:0002171HP:0002171Gliosis0C9ORF72 CL E G H20322828337ORPHA:275872Frontotemporal dementia with motor neuron diseaseHP:0040282 - Frequent56
HP:0002171HP:0002171Gliosis0CHCHD10 CL E G H40091615559ORPHA:275872Frontotemporal dementia with motor neuron diseaseHP:0040282 - Frequent11
HP:0002171HP:0002171Gliosis0COX15 CL E G H13552263OMIM:615119Mitochondrial complex IV deficiency, nuclear type 6.104
HP:0002171HP:0002171Gliosis0CSF1R CL E G H14362433OMIM:221820Leukoencephalopathy, diffuse hereditary, with spheroids.149
HP:0002171HP:0002171Gliosis0CYP27A1 CL E G H15932605ORPHA:909Cerebrotendinous xanthomatosisHP:0040283 - Occasional114
HP:0002171HP:0002171Gliosis0DNAJC13 CL E G H2331730343ORPHA:411602Hereditary late-onset Parkinson diseaseHP:0040283 - Occasional2
HP:0002171HP:0002171Gliosis0DTYMK CL E G H18413061OMIM:619847
HP:0002171HP:0002171Gliosis0DYRK1A CL E G H18593091ORPHA:268261DYRK1A-related intellectual disability syndrome due to 21q22.13q22.2 microdeletionHP:0040283 - Occasional134
HP:0002171HP:0002171Gliosis0EHMT1 CL E G H7981324650ORPHA:261652Kleefstra syndrome due to a point mutationHP:0040284 - Very rare223
HP:0002171HP:0002171Gliosis0EIF2B1 CL E G H19673257OMIM:603896Leukoencephalopathy with vanishing white matter.42
HP:0002171HP:0002171Gliosis0EIF2B2 CL E G H88923258OMIM:603896Leukoencephalopathy with vanishing white matter.24
HP:0002171HP:0002171Gliosis0EIF2B3 CL E G H88913259OMIM:603896Leukoencephalopathy with vanishing white matter.32
HP:0002171HP:0002171Gliosis0EIF2B4 CL E G H88903260OMIM:603896Leukoencephalopathy with vanishing white matter.38
HP:0002171HP:0002171Gliosis0EIF2B5 CL E G H88933261OMIM:603896Leukoencephalopathy with vanishing white matter.48
HP:0002171HP:0002171Gliosis0EIF4G1 CL E G H19813296ORPHA:411602Hereditary late-onset Parkinson diseaseHP:0040283 - Occasional2
HP:0002171HP:0002171Gliosis0ERCC6 CL E G H20743438OMIM:214150Cerebrooculofacioskeletal syndrome 1.199
HP:0002171HP:0002171Gliosis0ETFA CL E G H21083481OMIM:231680Multiple acyl-coa dehydrogenase deficiency.37
HP:0002171HP:0002171Gliosis0ETFB CL E G H21093482OMIM:231680Multiple acyl-coa dehydrogenase deficiency.27
HP:0002171HP:0002171Gliosis0ETFDH CL E G H21103483OMIM:231680Multiple acyl-coa dehydrogenase deficiency.77
HP:0002171HP:0002171Gliosis0FARS2 CL E G H1066721062OMIM:614946Combined oxidative phosphorylation deficiency 14.36
HP:0002171HP:0002171Gliosis0FBXO7 CL E G H2579313586ORPHA:171695Parkinsonian-pyramidal syndrome36
HP:0002171HP:0002171Gliosis0FUS CL E G H25214010ORPHA:275872Frontotemporal dementia with motor neuron diseaseHP:0040282 - Frequent105
HP:0002171HP:0002171Gliosis0GBA1 CL E G H26294177ORPHA:411602Hereditary late-onset Parkinson diseaseHP:0040283 - Occasional
HP:0002171HP:0002171Gliosis0GBA1 CL E G H26294177OMIM:168600Parkinson disease, late-onset
HP:0002171HP:0002171Gliosis0GDAP2 CL E G H5483418010OMIM:618369Spinocerebellar ataxia, autosomal recessive 27.
HP:0002171HP:0002171Gliosis0GIGYF2 CL E G H2605811960ORPHA:411602Hereditary late-onset Parkinson diseaseHP:0040283 - Occasional8
HP:0002171HP:0002171Gliosis0GLUD2 CL E G H27474336OMIM:168600Parkinson disease, late-onset1
HP:0002171HP:0002171Gliosis0GRN CL E G H28964601OMIM:607485Frontotemporal lobar degeneration with TDP43 inclusions.126
HP:0002171HP:0002171Gliosis0HSD17B4 CL E G H32955213OMIM:261515D-bifunctional protein deficiency.98
HP:0002171HP:0002171Gliosis0HTT CL E G H30644851OMIM:143100Huntington disease.12
HP:0002171HP:0002171Gliosis0KCNT1 CL E G H5758218865OMIM:614959Epileptic encephalopathy, early infantile, 14.321
HP:0002171HP:0002171Gliosis0KDM3B CL E G H517801337OMIM:618846DIETS-JONGMANS SYNDROME; DIJOS
HP:0002171HP:0002171Gliosis0KMT2C CL E G H5850813726ORPHA:261652Kleefstra syndrome due to a point mutationHP:0040284 - Very rare99
HP:0002171HP:0002171Gliosis0L2HGDH CL E G H7994420499OMIM:236792L-2-Hydroxyglutaric aciduria.34
HP:0002171HP:0002171Gliosis0LMNB1 CL E G H40016637OMIM:169500Leukodystrophy, adult-onset, autosomal dominant.44
HP:0002171HP:0002171Gliosis0LONP1 CL E G H93619479ORPHA:79243Pyruvate dehydrogenase E1-alpha deficiencyHP:0040282 - Frequent8
HP:0002171HP:0002171Gliosis0LRPPRC CL E G H1012815714OMIM:220111Leigh syndrome, french Canadian type.191
HP:0002171HP:0002171Gliosis0LRRK2 CL E G H12089218618ORPHA:411602Hereditary late-onset Parkinson diseaseHP:0040283 - Occasional221
HP:0002171HP:0002171Gliosis0LRRK2 CL E G H12089218618OMIM:607060Parkinson disease 8, autosomal dominant221
HP:0002171HP:0002171Gliosis0MAN2B1 CL E G H41256826OMIM:248500Alpha-mannosidosis.136
HP:0002171HP:0002171Gliosis0MAPT CL E G H41376893OMIM:168600Parkinson disease, late-onset140
HP:0002171HP:0002171Gliosis0MAPT CL E G H41376893OMIM:172700Pick disease of brain.140
HP:0002171HP:0002171Gliosis0MAPT CL E G H41376893OMIM:601104Supranuclear palsy, progressive, 1.140
HP:0002171HP:0002171Gliosis0MOCS1 CL E G H43377190OMIM:252150Molybdenum cofactor deficiency, complementation group A.96
HP:0002171HP:0002171Gliosis0MOCS2 CL E G H43387193OMIM:252160Molybdenum cofactor deficiency, complementation group B.26
HP:0002171HP:0002171Gliosis0MTOR CL E G H24753942ORPHA:99802HemimegalencephalyHP:0040283 - Occasional68
HP:0002171HP:0002171Gliosis0NARS2 CL E G H7973126274OMIM:616239Combined oxidative phosphorylation deficiency 24.34
HP:0002171HP:0002171Gliosis0NAXD CL E G H5573925576OMIM:618321Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 2.
HP:0002171HP:0002171Gliosis0NDUFAF3 CL E G H2591529918ORPHA:70474Leigh syndrome with cardiomyopathy31
HP:0002171HP:0002171Gliosis0NDUFB8 CL E G H47147703ORPHA:70474Leigh syndrome with cardiomyopathy
HP:0002171HP:0002171Gliosis0NDUFS2 CL E G H47207708ORPHA:70474Leigh syndrome with cardiomyopathy65
HP:0002171HP:0002171Gliosis0NDUFS8 CL E G H47287715OMIM:618222Mitochondrial complex I deficiency, nuclear type 242
HP:0002171HP:0002171Gliosis0NGLY1 CL E G H5576817646ORPHA:404454Alacrimia-choreoathetosis-liver dysfunction syndromeHP:0040283 - Occasional32
HP:0002171HP:0002171Gliosis0NGLY1 CL E G H5576817646OMIM:615273Congenital disorder of deglycosylation32
HP:0002171HP:0002171Gliosis0NR4A2 CL E G H49297981OMIM:168600Parkinson disease, late-onset27
HP:0002171HP:0002171Gliosis0NUP62 CL E G H236368066ORPHA:225154Familial infantile bilateral striatal necrosis7
HP:0002171HP:0002171Gliosis0PAX2 CL E G H50768616OMIM:120330Papillorenal syndrome.39
HP:0002171HP:0002171Gliosis0PDHA1 CL E G H51608806ORPHA:79243Pyruvate dehydrogenase E1-alpha deficiencyHP:0040282 - Frequent88
HP:0002171HP:0002171Gliosis0PIGA CL E G H52778957OMIM:300868Multiple congenital anomalies-hypotonia-seizures syndrome 2.46
HP:0002171HP:0002171Gliosis0PIGA CL E G H52778957OMIM:301072NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HEMOCHROMATOSIS; NEDEPH46
HP:0002171HP:0002171Gliosis0PIK3CA CL E G H52908975ORPHA:99802HemimegalencephalyHP:0040283 - Occasional162
HP:0002171HP:0002171Gliosis0PLA2G6 CL E G H83989039ORPHA:35069Infantile neuroaxonal dystrophy133
HP:0002171HP:0002171Gliosis0PLA2G6 CL E G H83989039OMIM:256600Neurodegeneration with brain iron accumulation 2A.133
HP:0002171HP:0002171Gliosis0PLP1 CL E G H53549086ORPHA:280210Pelizaeus-Merzbacher disease, connatal formHP:0040281 - Very frequent60
HP:0002171HP:0002171Gliosis0PMPCA CL E G H2320318667OMIM:213200Spinocerebellar ataxia, autosomal recessive 2.7
HP:0002171HP:0002171Gliosis0POLG CL E G H54289179OMIM:203700Mitochondrial DNA depletion syndrome 4A (Alpers type).464
HP:0002171HP:0002171Gliosis0PRKN CL E G H50718607OMIM:600116Parkinson disease, juvenile, type 2138
HP:0002171HP:0002171Gliosis0PRNP CL E G H56219449ORPHA:157941Huntington disease-like 1HP:0040283 - Occasional69
HP:0002171HP:0002171Gliosis0PRNP CL E G H56219449OMIM:603218Huntington disease-like 169
HP:0002171HP:0002171Gliosis0PRNP CL E G H56219449OMIM:606688Spongiform encephalopathy with neuropsychiatric features.69
HP:0002171HP:0002171Gliosis0PSEN1 CL E G H56639508OMIM:172700Pick disease of brain.241
HP:0002171HP:0002171Gliosis0RANBP2 CL E G H59039848OMIM:608033Encephalopathy, acute, infection-induced, susceptibility to, 3.57
HP:0002171HP:0002171Gliosis0RANBP2 CL E G H59039848ORPHA:88619Familial acute necrotizing encephalopathyHP:0040282 - Frequent57
HP:0002171HP:0002171Gliosis0SCO2 CL E G H999710604OMIM:604377Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 140
HP:0002171HP:0002171Gliosis0SCO2 CL E G H999710604ORPHA:70474Leigh syndrome with cardiomyopathy40
HP:0002171HP:0002171Gliosis0SERPINI1 CL E G H52748943OMIM:604218Encephalopathy, familial, with neuroserpin inclusion bodies.28
HP:0002171HP:0002171Gliosis0SLC25A46 CL E G H9113725198OMIM:616505Neuropathy, hereditary motor and sensory, type VIB14
HP:0002171HP:0002171Gliosis0SNCA CL E G H662211138ORPHA:411602Hereditary late-onset Parkinson diseaseHP:0040283 - Occasional65
HP:0002171HP:0002171Gliosis0SNCA CL E G H662211138OMIM:168601Parkinson disease 1, autosomal dominant.65
HP:0002171HP:0002171Gliosis0SNCA CL E G H662211138ORPHA:171695Parkinsonian-pyramidal syndrome65
HP:0002171HP:0002171Gliosis0SNCAIP CL E G H962711139OMIM:168600Parkinson disease, late-onset35
HP:0002171HP:0002171Gliosis0SQSTM1 CL E G H887811280ORPHA:275872Frontotemporal dementia with motor neuron diseaseHP:0040282 - Frequent62
HP:0002171HP:0002171Gliosis0SURF1 CL E G H683411474ORPHA:70474Leigh syndrome with cardiomyopathy73
HP:0002171HP:0002171Gliosis0TARDBP CL E G H2343511571ORPHA:275872Frontotemporal dementia with motor neuron diseaseHP:0040282 - Frequent65
HP:0002171HP:0002171Gliosis0TBCD CL E G H690411581OMIM:617193ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT16
HP:0002171HP:0002171Gliosis0TBK1 CL E G H2911011584ORPHA:275872Frontotemporal dementia with motor neuron diseaseHP:0040282 - Frequent20
HP:0002171HP:0002171Gliosis0TBP CL E G H690811588OMIM:168600Parkinson disease, late-onset7
HP:0002171HP:0002171Gliosis0TBP CL E G H690811588OMIM:607136Spinocerebellar ataxia 17.7
HP:0002171HP:0002171Gliosis0TFG CL E G H1034211758OMIM:604484Neuropathy, hereditary motor and sensory, Okinawa type.18
HP:0002171HP:0002171Gliosis0THOC2 CL E G H5718719073OMIM:300957Mental retardation, X-linked 12/355
HP:0002171HP:0002171Gliosis0THOC2 CL E G H5718719073ORPHA:457240X-linked intellectual disability-short stature-overweight syndromeHP:0040283 - Occasional5
HP:0002171HP:0002171Gliosis0TLR3 CL E G H709811849OMIM:613002Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 2.3
HP:0002171HP:0002171Gliosis0TRNT CL E G H45767499OMIM:168600Parkinson disease, late-onset
HP:0002171HP:0002171Gliosis0TSEN54 CL E G H28398927561OMIM:277470Pontocerebellar hypoplasia, type 2A.102
HP:0002171HP:0002171Gliosis0TSEN54 CL E G H28398927561OMIM:225753Pontocerebellar hypoplasia, type 4.102
HP:0002171HP:0002171Gliosis0TYROBP CL E G H730512449OMIM:221770Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy.22
HP:0002171HP:0002171Gliosis0UBQLN2 CL E G H2997812509OMIM:300857Amyotrophic lateral sclerosis 15 with or without frontotemporal dementia.20
HP:0002171HP:0002171Gliosis0VCP CL E G H741512666ORPHA:275872Frontotemporal dementia with motor neuron diseaseHP:0040282 - Frequent63
HP:0002171HP:0002171Gliosis0VPS35 CL E G H5573713487ORPHA:411602Hereditary late-onset Parkinson diseaseHP:0040283 - Occasional37
HP:0002171HP:0002171Gliosis0VRK1 CL E G H744312718OMIM:607596Pontocerebellar hypoplasia type 1A32
HP:0002171HP:0002171Gliosis0YY1 CL E G H752812856ORPHA:506358Gabriele-de Vries syndromeHP:0040283 - Occasional7
HP:0002171HP:0002171Gliosis0ZNF335 CL E G H6392515807OMIM:615095Microcephaly 10, primary, autosomal recessive.60
HP:0002171HP:0033715Hippocampal sclerosis1 CL E G H
HP:0002171HP:0025037Hypothalamic gliosis1 CL E G H
HP:0002171HP:0006990Myelin-dependent gliosis1 CL E G H
HP:0002171HP:0006999Basal ganglia gliosis1ADAR CL E G H103225ORPHA:225154Familial infantile bilateral striatal necrosisHP:0040282 - Frequent116
HP:0002171HP:0011960Substantia nigra gliosis1ADH1C CL E G H126251OMIM:168600Parkinson disease, late-onset.4
HP:0002171HP:0006999Basal ganglia gliosis1ATP6 CL E G H45087414ORPHA:225154Familial infantile bilateral striatal necrosisHP:0040282 - Frequent
HP:0002171HP:0011960Substantia nigra gliosis1ATXN2 CL E G H631110555OMIM:168600Parkinson disease, late-onset.11
HP:0002171HP:0011960Substantia nigra gliosis1ATXN3 CL E G H42877106ORPHA:276238Machado-Joseph disease type 1HP:0040282 - Frequent14
HP:0002171HP:0011960Substantia nigra gliosis1ATXN3 CL E G H42877106ORPHA:276241Machado-Joseph disease type 2HP:0040282 - Frequent14
HP:0002171HP:0011960Substantia nigra gliosis1ATXN3 CL E G H42877106ORPHA:276244Machado-Joseph disease type 3HP:0040282 - Frequent14
HP:0002171HP:0011960Substantia nigra gliosis1ATXN8OS CL E G H631510561OMIM:168600Parkinson disease, late-onset.1
HP:0002171HP:0006999Basal ganglia gliosis1FARS2 CL E G H1066721062OMIM:614946Combined oxidative phosphorylation deficiency 1436
HP:0002171HP:0011960Substantia nigra gliosis1FBXO7 CL E G H2579313586ORPHA:171695Parkinsonian-pyramidal syndromeHP:0040282 - Frequent36
HP:0002171HP:0011960Substantia nigra gliosis1GBA1 CL E G H26294177OMIM:168600Parkinson disease, late-onset.
HP:0002171HP:0011960Substantia nigra gliosis1GLUD2 CL E G H27474336OMIM:168600Parkinson disease, late-onset.1
HP:0002171HP:0012698Cerebellar gliosis1LONP1 CL E G H93619479ORPHA:79243Pyruvate dehydrogenase E1-alpha deficiencyHP:0040283 - Occasional8
HP:0002171HP:0006999Basal ganglia gliosis1LONP1 CL E G H93619479ORPHA:79243Pyruvate dehydrogenase E1-alpha deficiencyHP:0040283 - Occasional8
HP:0002171HP:0011960Substantia nigra gliosis1LRRK2 CL E G H12089218618OMIM:607060Parkinson disease 8, autosomal dominant.221
HP:0002171HP:0011960Substantia nigra gliosis1MAPT CL E G H41376893OMIM:168600Parkinson disease, late-onset.140
HP:0002171HP:0006999Basal ganglia gliosis1NDUFAF3 CL E G H2591529918ORPHA:70474Leigh syndrome with cardiomyopathyHP:0040282 - Frequent31
HP:0002171HP:0006999Basal ganglia gliosis1NDUFB8 CL E G H47147703ORPHA:70474Leigh syndrome with cardiomyopathyHP:0040282 - Frequent
HP:0002171HP:0006999Basal ganglia gliosis1NDUFS2 CL E G H47207708ORPHA:70474Leigh syndrome with cardiomyopathyHP:0040282 - Frequent65
HP:0002171HP:0011960Substantia nigra gliosis1NR4A2 CL E G H49297981OMIM:168600Parkinson disease, late-onset.27
HP:0002171HP:0006999Basal ganglia gliosis1NUP62 CL E G H236368066ORPHA:225154Familial infantile bilateral striatal necrosisHP:0040282 - Frequent7
HP:0002171HP:0012698Cerebellar gliosis1PDHA1 CL E G H51608806ORPHA:79243Pyruvate dehydrogenase E1-alpha deficiencyHP:0040283 - Occasional88
HP:0002171HP:0006999Basal ganglia gliosis1PDHA1 CL E G H51608806ORPHA:79243Pyruvate dehydrogenase E1-alpha deficiencyHP:0040283 - Occasional88
HP:0002171HP:0012698Cerebellar gliosis1PLA2G6 CL E G H83989039ORPHA:35069Infantile neuroaxonal dystrophyHP:0040282 - Frequent133
HP:0002171HP:0011960Substantia nigra gliosis1PRKN CL E G H50718607OMIM:600116Parkinson disease, juvenile, type 2.138
HP:0002171HP:0006999Basal ganglia gliosis1PRNP CL E G H56219449OMIM:603218Huntington disease-like 169
HP:0002171HP:0006999Basal ganglia gliosis1SCO2 CL E G H999710604OMIM:604377Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1.40
HP:0002171HP:0006999Basal ganglia gliosis1SCO2 CL E G H999710604ORPHA:70474Leigh syndrome with cardiomyopathyHP:0040282 - Frequent40
HP:0002171HP:0012698Cerebellar gliosis1SLC25A46 CL E G H9113725198OMIM:616505Neuropathy, hereditary motor and sensory, type VIB14
HP:0002171HP:0011960Substantia nigra gliosis1SNCA CL E G H662211138ORPHA:171695Parkinsonian-pyramidal syndromeHP:0040282 - Frequent65
HP:0002171HP:0011960Substantia nigra gliosis1SNCAIP CL E G H962711139OMIM:168600Parkinson disease, late-onset.35
HP:0002171HP:0006999Basal ganglia gliosis1SURF1 CL E G H683411474ORPHA:70474Leigh syndrome with cardiomyopathyHP:0040282 - Frequent73
HP:0002171HP:0011960Substantia nigra gliosis1TBP CL E G H690811588OMIM:168600Parkinson disease, late-onset.7
HP:0002171HP:0011960Substantia nigra gliosis1TRNT CL E G H45767499OMIM:168600Parkinson disease, late-onset.
HP:0002171HP:0006999Basal ganglia gliosis1VRK1 CL E G H744312718OMIM:607596Pontocerebellar hypoplasia type 1A.32


Genes (99) :ADAR ADH1C AKT3 AP4M1 ARX ATP6 ATP6V1A ATXN2 ATXN3 ATXN8OS AVP BCS1L BRAT1 C9ORF72 CHCHD10 COX15 CSF1R CYP27A1 DNAJC13 DTYMK DYRK1A EHMT1 EIF2B1 EIF2B2 EIF2B3 EIF2B4 EIF2B5 EIF4G1 ERCC6 ETFA ETFB ETFDH FARS2 FBXO7 FUS GBA1 GDAP2 GIGYF2 GLUD2 GRN HSD17B4 HTT KCNT1 KDM3B KMT2C L2HGDH LMNB1 LONP1 LRPPRC LRRK2 MAN2B1 MAPT MOCS1 MOCS2 MTOR NARS2 NAXD NDUFAF3 NDUFB8 NDUFS2 NDUFS8 NGLY1 NR4A2 NUP62 PAX2 PDHA1 PIGA PIK3CA PLA2G6 PLP1 PMPCA POLG PRKN PRNP PSEN1 RANBP2 SCO2 SERPINI1 SLC25A46 SNCA SNCAIP SQSTM1 SURF1 TARDBP TBCD TBK1 TBP TFG THOC2 TLR3 TRNT TSEN54 TYROBP UBQLN2 VCP VPS35 VRK1 YY1 ZNF335

Diseases (80) :ORPHA:225154 OMIM:168600 ORPHA:99802 OMIM:612936 OMIM:300215 OMIM:617403 OMIM:109150 ORPHA:276238 ORPHA:276241 ORPHA:276244 OMIM:125700 OMIM:124000 OMIM:614498 OMIM:105550 ORPHA:275872 OMIM:615119 OMIM:221820 ORPHA:909 ORPHA:411602 OMIM:619847 ORPHA:268261 ORPHA:261652 OMIM:603896 OMIM:214150 OMIM:231680 OMIM:614946 ORPHA:171695 OMIM:618369 OMIM:607485 OMIM:261515 OMIM:143100 OMIM:614959 OMIM:618846 OMIM:236792 OMIM:169500 ORPHA:79243 OMIM:220111 OMIM:607060 OMIM:248500 OMIM:172700 OMIM:601104 OMIM:252150 OMIM:252160 OMIM:616239 OMIM:618321 ORPHA:70474 OMIM:618222 ORPHA:404454 OMIM:615273 OMIM:120330 OMIM:300868 OMIM:301072 ORPHA:35069 OMIM:256600 ORPHA:280210 OMIM:213200 OMIM:203700 OMIM:600116 ORPHA:157941 OMIM:603218 OMIM:606688 OMIM:608033 ORPHA:88619 OMIM:604377 OMIM:604218 OMIM:616505 OMIM:168601 OMIM:617193 OMIM:607136 OMIM:604484 OMIM:300957 ORPHA:457240 OMIM:613002 OMIM:277470 OMIM:225753 OMIM:221770 OMIM:300857 OMIM:607596 ORPHA:506358 OMIM:615095
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.